Related Experiment Video
Updated: Aug 5, 2026
07:20
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Autophagy in MASLD: A Metabolic and Precision Medicine Perspective
Alessandra Cazzaniga1, Silvia Frigo2, Alessandro Cherubini2
1Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Summary
Metabolic dysfunction-associated steatotic liver disease (MASLD) is linked to impaired autophagy, a cellular process crucial for liver health. Restoring autophagy may offer new personalized treatments for this common liver condition.
Area of Science:
- Hepatology and Cellular Biology
- Metabolic Disorders
- Genetics of Liver Disease
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent global liver condition, often progressing to cirrhosis and hepatocellular carcinoma (HCC).
- Key metabolic factors like obesity and insulin resistance drive MASLD, but impaired autophagy, a cellular quality control mechanism, is increasingly recognized as central to its progression.
Purpose of the Study:
- To explore the role of impaired autophagy in MASLD pathogenesis.
- To investigate genetic factors influencing MASLD susceptibility through autophagy defects.
- To propose a precision-medicine framework for MASLD therapeutics targeting autophagy.
Main Methods:
- Review of experimental studies linking autophagic flux to liver injury in MASLD.
- Analysis of human genetic data implicating autophagy-related genes (e.g., ATG7) and modifiers (e.g., PNPLA3 variants) in MASLD.
- Examination of emerging therapies aimed at restoring autophagic flux.
Main Results:
- Disruption of autophagy, including lipophagy and mitophagy, contributes to lipid accumulation, oxidative stress, and hepatocellular damage in MASLD.
- Genetic variants in PNPLA3 and ATG7 are associated with increased risk of MASLD progression, including ballooning, fibrosis, and HCC.
- Impaired autophagic flux is experimentally linked to liver injury and genetically linked to MASLD susceptibility.
Conclusions:
- Autophagy defects are critical drivers of MASLD progression and its severe complications.
- Genetic variations influencing autophagy significantly impact individual susceptibility to MASLD.
- Targeting autophagy restoration presents a promising avenue for developing personalized therapies for MASLD.
Related Concept Videos
01:27Autophagy
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
01:36Delivery Pathways to the Lysosome
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
01:18Autophagic Cell Death
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...